Syngene’s Target Identification and Validation services combine data, informatics, and knowledge about biological target assays for holistic target assessment and risk mitigation in drug discovery.

Syngene’s Center of Excellence for Nitrosamine impurity testing supports formulation requirements for small molecule APIs, key sourcing materials, and intermediates.

Syngene offers integrated solutions for PROTAC (including tools) to seamlessly move your molecule from early proof-of-concept to identification of the development candidate.

Syngene offers comprehensive Animal Healthcare services across the drug discovery, development, and manufacturing continuum for small molecules and biologics.

Syngene has one of the largest Analytical facilities in Asia. The facility supports small and large molecules programs from early development to CMC filing and commercialization.

Syngene offers integrated and standalone services across the drug discovery continuum from Target Identification to IND enabling.

Syngene’s Sterile Fill-Finish facility is custom-built to meet market demand for clinical supply of sterile drug products having short development timelines.

Syngene, with its comprehensive suite of DMPK profiling assays, can help you achieve a high rate of success with your clinical candidates across drug modalities.

Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.

SynVantage is Syngene’s platform that enables a continuous and seamless transition between different stages of a DMTA cycle thereby reducing timelines for early drug discovery.